EUDA Health (NASDAQ:EUDA) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of EUDA Health (NASDAQ:EUDA) to a hold rating in a report issued on Saturday morning,Wall Street Zen reports.

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of EUDA Health in a report on Wednesday, August 5th. One research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $55.00.

EUDA Health Stock Down 2.6%

Shares of EUDA stock opened at $15.00 on Friday. EUDA Health has a 52-week low of $5.26 and a 52-week high of $71.80. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.53 and a quick ratio of 2.53. The company’s 50 day moving average is $15.45 and its 200 day moving average is $14.34.

EUDA Health (NASDAQ:EUDA) last posted its earnings results on Tuesday, September 29th. The company reported ($0.17) earnings per share for the quarter, missing analysts’ consensus estimates of $0.40 by ($0.57). The business had revenue of $1.73 million during the quarter, compared to the consensus estimate of $9.61 million.

About EUDA Health

EUDA Health Holdings Limited is a healthcare technology company focused on providing digital and technology-enabled healthcare services. Through its platform and affiliated healthcare operations, the company aims to connect patients with medical professionals and make healthcare services more accessible through digital channels.

Its activities include telehealth and online medical consultations, healthcare information and patient-management services, and related wellness and medical support offerings.